Home / Health / Cancer Patient Sells Home for Experimental Treatment
Cancer Patient Sells Home for Experimental Treatment
17 Jul
Summary
- Woman sold home for advanced cancer treatment not on NHS.
- Glioblastoma diagnosis led to desperate measures for care.
- Advocacy group urges government investment in research.
A Nottinghamshire woman, Jo Fuller, 51, has sold her home to finance potentially life-extending treatment for an aggressive form of brain cancer, glioblastoma. Fuller, a dyslexia specialist, was diagnosed almost two years ago while on holiday in Australia. Standard treatments proved unsuccessful, leading her to pursue hyperthermia, a method of heating tumor tissues, alongside consultations with an alternative oncologist, repurposed medications, and nutritional supplements.
Hyperthermia, while used experimentally for brain tumors, is not routinely funded by the NHS. Fuller's personal sacrifice underscores the challenges patients face when seeking advanced or experimental therapies. Her situation is a stark example of the difficult decisions some must make to access care, prompting Brain Tumour Research to urge the government to increase investment in research and expand clinical trial access.
Fuller hopes to access further experimental treatments, such as IOZK immunotherapy in Germany, if her condition requires it. She expressed a strong refusal to let her diagnosis dictate her future and highlighted the urgent need for more research to provide better treatment options and greater hope for patients and their families.
The Department of Health and Social Care acknowledged Fuller's situation, stating that improving cancer research and care is a government priority. They highlighted ongoing support for groundbreaking trials through the National Institute for Health and Care Research, aiming to bring scientific breakthroughs to patients faster.
